JP MORGAN/PUT/BECTON DICKINSON AND CO./225/0.1/20.09.24 Share Price

Warrant

DE000JK1PNB3

Real-time Bid/Ask 13:45:57 27/06/2024 BST
1.02 EUR / 1.09 EUR +17.22% Intraday chart for JP MORGAN/PUT/BECTON DICKINSON AND CO./225/0.1/20.09.24
Current month-36.62%
1 month-27.42%
Date Price Change
27/06/24 1.01 +12.22%
25/06/24 0.9 +9.76%
24/06/24 0.82 -5.75%
21/06/24 0.87 -14.71%
20/06/24 1.02 -2.86%

Delayed Quote Börse Stuttgart

Last update June 27, 2024 at 01:42 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellPUT
Underlying BECTON, DICKINSON AND COMPANY
Issuer J.P. Morgan
WKN JK1PNB
ISINDE000JK1PNB3
Date issued 25/01/2024
Strike 225 $
Maturity 20/09/2024 (85 Days)
Parity 10 : 1
Emission price 0.86
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.83
Lowest since issue 0.82
Spread 0.07
Spread %6.36%

Company Profile

Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.; - diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.; - clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).
Sector
-
More about the company

Ratings for Becton, Dickinson and Company

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Becton, Dickinson and Company

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
231.6 USD
Average target price
279.2 USD
Spread / Average Target
+20.54%
Consensus